Clopidogrel Bisulphate 75mg + Aspirin 75mg | PETIVA-A 75

Clopidogrel Bisulphate 75mg + Aspirin 75mg is a dual antiplatelet therapy (DAPT) formulation used for the prevention of cardiovascular and thrombotic events. This combination contains Clopidogrel, a P2Y12 platelet inhibitor, and Aspirin, a non-steroidal anti-inflammatory drug (NSAID) with antiplatelet properties.

Together, these medicines prevent platelet aggregation and reduce the formation of harmful blood clots. It is commonly prescribed for patients with:

Acute coronary syndrome (ACS)

Myocardial infarction (heart attack)

Ischemic stroke

Peripheral arterial disease

Post-angioplasty or stent placement

This combination significantly lowers the risk of recurrent cardiovascular events and improves long-term cardiac outcomes when used under medical supervision.